Table 3.
Association of the three scores with treatment response of neoadjuvant chemotherapy for gastric cancer
| Cohorts | Models | Responding group | Non-responding group | OR (95% CI) | P value |
|---|---|---|---|---|---|
| Training cohort | rad_score | 0.56 ± 0.26 | 0.38 ± 0.25 | 14.51 (2.40, 98.35) | < 0.01 |
| clinical_score | 0.56 ± 0.11 | 0.47 ± 0.13 | 355.62 (7.98, 2.41*104) | < 0.01 | |
| rad_clinical score | −0.61 ± 0.29 | −0.88 ± 0.34 | 12.22 (2.79, 64.65) | < 0.01 | |
| Validation cohort | rad_score | 0.54 ± 0.12 | 0.42 ± 0.08 | 1.21*105 (52.25, 3.07*109) | < 0.01 |
| clinical_score | 0.52 ± 0.12 | 0.48 ± 0.11 | 33.46 (0.07, 2.98*104) | 0.28 | |
| rad_clinical score | −0.38 ± 0.23 | −0.56 ± 0.27 | 16.90 (1.04, 422.82) | 0.06 |
Abbreviations: OR odds ratio, CI confidence interval